EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Total Neoadjuvant Therapy with Induction FOLFIRINOX and Concurrent Chemoradiation for Locally Advanced Lower-Middle Rectal Cancer: A retrospective study in Vietnam

Hung Van Nguyen iD, Huy Le Trinh iD, Ngoc Dung Tran, Manh Duy Pham, Duc Khac Duong, Linh Thuy Duong, Thi Hoan Pham, Huyen Thi Phan, Trung Bach Tran, Hau Xuan Nguyen

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251398075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Hung Van Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Rectal Neoplasms, Neoadjuvant Therapy, Chemoradiotherapy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Locally advanced rectal cancer (LARC) remains a therapeutic challenge, with significant risks of both locoregional and distant relapse. Total neoadjuvant therapy (TNT), which combines induction chemotherapy and chemoradiotherapy (CRT) prior to surgery, has emerged as a potentially more effective strategy than traditional approaches, yet data from low- and middle-income countries (LMICs) remain limited. This study evaluates the efficacy and toxicity of induction FOLFIRINOX followed by concurrent CRT in Vietnamese patients with lower–middle LARC.

Methods

A retrospective analysis was conducted on adult patients ( n = 72) with clinical stage T3–T4 M0 rectal adenocarcinoma. All patients received induction FOLFIRINOX for six cycles and preoperative CRT, followed by total meso-rectal excision (TME), and adjuvant chemotherapy as indicated. The primary endpoint was pathologic complete response (pCR, ypT0N0); secondary endpoints were 3-year disease-free survival (DFS) and safety. The study conforms to STROBE guidelines.

Results

Pathological complete response was achieved in 25.0% of patients. The 3-year DFS reached 90.6%. Treatment feasibility was high, with 93.06% completing all 6 induction cycles; hematologic adverse events, particularly leukopenia and neutropenia, were the most common toxicities but were generally manageable with supportive care, while nonhematological toxicities were predominantly mild. R0 resection rate was 100% and sphincter-preserving surgery was 86.1%.

Conclusion

In a LMIC setting, induction FOLFIRINOX followed by CRT shows promising efficacy and tolerable toxicity in LARC. These findings support early, intensified systemic therapy to enhance local control and mitigate metastatic spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsRectal NeoplasmsNeoadjuvant TherapyChemoradiotherapyHumansMaleFemaleMiddle AgedRetrospective StudiesFluorouracilLeucovorinAdultAgedOxaliplatinIrinotecanVietnamNeoplasm StagingTreatment OutcomeInduction ChemotherapyCombined Modality Therapy

Stichwörter der Autor:innen

FOLFIRINOXLMICVietnamlocally advanced rectal cancertotal neoadjuvant therapy

Substanzen

FluorouracilLeucovorinOxaliplatinfolfirinoxIrinotecan

Autor:innen und Institutionen

  • Department of Oncology, Hanoi Medical University, Hanoi, Vietnam.
  • Oncology Center, Hanoi Medical University Hospital, Hanoi, Vietnam.
  • Department of Coloproctology and Pelvic Floor Surgery, Hanoi Medical University Hospital, Hanoi, Vietnam.
  • Department of Radiation, Military 103 Hospital, Hanoi, Vietnam.
  • Department of Pathology, Hanoi Medical University Hospital, Hanoi, Vietnam.
  • Department of Radiation Oncology 5, K Hospital, Hanoi, Vietnam.

ORCID-Profile: Hung Van Nguyen, Huy Le Trinh

Zitieren

APA

Nguyen, H. V., Trinh, H. L., Tran, N. D., Pham, M. D., Duong, D. K., Duong, L. T., Pham, T. H., Phan, H. T., Tran, T. B., & Nguyen, H. X. (2025). Total Neoadjuvant Therapy with Induction FOLFIRINOX and Concurrent Chemoradiation for Locally Advanced Lower-Middle Rectal Cancer: A retrospective study in Vietnam. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251398075

Vancouver

Nguyen HV, Trinh HL, Tran ND, Pham MD, Duong DK, Duong LT, et al. Total Neoadjuvant Therapy with Induction FOLFIRINOX and Concurrent Chemoradiation for Locally Advanced Lower-Middle Rectal Cancer: A retrospective study in Vietnam. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251398075

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Hung Van and Trinh, Huy Le and Tran, Ngoc Dung and Pham, Manh Duy and Duong, Duc Khac and Duong, Linh Thuy and Pham, Thi Hoan and Phan, Huyen Thi and Tran, Trung Bach and Nguyen, Hau Xuan},
  title = {Total Neoadjuvant Therapy with Induction FOLFIRINOX and Concurrent Chemoradiation for Locally Advanced Lower-Middle Rectal Cancer: A retrospective study in Vietnam},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251398075}
}
Kostenlos starten →